[1] 张龙玉,孙颖,黄昂,等. 酒精性肝病患者肝组织NLRP3炎症复合体基因水平检测及其意义. 实用肝脏病杂志,2016,19:678-682.
[2] Park MS, Hong S, Lim YL, et al. Measuring intrahepatic vascular changes using contrast-enhanced ultrasonography to predict the prognosis of alcoholic hepatitis combined with cirrhosis: a prospective pilot study. Gut Liver,2018,12:555-561.
[3] 王红钢,孙伟力,钟培育,等. 外源性硫化氢对肝细胞NLRP3炎症小体的影响. 中国病理生理杂志,2018,12:555-561.
[4] Mellinger JL, Shedden K, Winder GS, et al. The high burden of alcoholic cirrhosis in privately insured persons in the United States. Hepatology,2018,68:872-882.
[5] Begon E, Beneton N, Poiraud C, et al. Safety and efficacy of biologic therapies in psoriatic patients with alcoholic cirrhosis: a French retrospective study of 23 cases. Br J Dermatol.,2018,179:512-513.
[6] Singh A, Pandey B. A new intelligent medical decision support system based on enhanced hierarchical clustering and random decision forest for the classification of alcoholic liver damage, primary hepatoma, liver cirrhosis, and cholelithiasis. J Healthc Eng,2018,2018:1469043.
[7] 汪涛,刘慧,雷蕾,等. NLRP3基因过表达载体的建立及鉴定. 基因组学与应用生物学,2017,36:3511-3515.
[8] 俞佳,周垚,厉瑶,等. 茵陈芍甘汤对内毒素性急性肝损伤小鼠NLRP3炎症小体的影响. 中华中医药学刊,2015,33:2734-2737.
[9] 潮蓉,武小娟,王羽辉,等. P2X7R/NLRP3信号通路在酒精性肝损伤中的作用. 中国药理学通报,2018,34:491-495.
[10] 汪玉兰,陈伟庆. 乙型肝炎病毒X蛋白对核苷酸结合寡聚化结构域样受体蛋白3炎性小体的激活及机制研究. 中华消化外科杂志,2016,15:615-621. |
